medigraphic.com
ISSN 1405-1699 (Impreso)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

1999, Número 4

<< Anterior

Alerg Asma Inmunol Pediatr 1999; 8 (4)


Chlamydia pneumoniae y su papel en la inmunoalergia

Yamasaky NMA, López PG

Idioma: Español
Referencias bibliográficas: 34
Paginas: 118-120
Archivo PDF: 213.84 Kb.


RESUMEN

La Chlamydia pneumoniae es una bacteria recientemente descrita que ha sido implicada en una gran diversidad de entidades clínicas desde su papel como agente causal de infecciones de las vías aéreas hasta su rol en la patogénesis de la aterosclerosis. Describimos brevemente su relación con padecimientos alérgicos e inmunológicos así como su diagnóstico y tratamiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Becker Y. Chlamydia. En: Baron S. Medical Microbiology. 4th edition, The University of Texas Medical Branch at Galveston 1996; 503-513.

  2. Hatch T. Chlamydia: old ideas crushed, new mysteries bared. Science 1998; 282: 638-9.

  3. American Academy of Pediatrics. Chlamydia pneumoniae. En: Peter G., ed. Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1997: 168.

  4. Grayston JT. Chlamydia pneumoniae, strain TWAR. Chest 1989; 95: 664-9.

  5. Marrie T. Chlamydia pneumoniae, Thorax 1993; 48: 1-4.

  6. Saikku P, Leinonen M, Mattila K. Serological evidence of an association of a novel Chlamydia, TWAR, with coronary heart disease and acute myocardial infection. Lancet 1988; 938-986.

  7. Grayston JT, Kuo CC, Campbell LA, Beditt EP. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993; 14(suppl): 66-71.

  8. Thom DH, Grauston JT, Siscovick DS. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.

  9. Gloria F, Meaney E, Valero G. La relación entre Chlamydia pneumoniae y las lesiones aterosclerosas aórticas. Arch Inst Cardiol Mex 1997; 67: 17-23.

  10. Ridker PM, Kundsin RB, Stampfer MJ. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 99: 1161-4.

  11. Altman R, Rouvier J, Scazziota A. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease. Clin Cardiol 1999; 22: 85-90.

  12. Normann E, Gnarpe J, Gnarpe H. Chlamydia pneumoniae in children attending day care centers in Gävle, Sweden. Pediatr Infect Dis J 1998; 17: 474-8.

  13. McMillan J. Chlamydia pneumoniae revisited. Pediatr Infect Dis J 1998; 17: 1045-1048.

  14. Falck G, Engstrand I, Gnarpe J. Association of Chlamydia pneumoniae with otitis media in children. Scand Infect Dis 1998; 30: 377-80.

  15. Hagiwara K, Ouchi K, Tashiro N. An epidemic of a pertussis like illness caused by Chlamydia pneumoniae. Pediatr Infect Dis J 1999; 18: 271-5.

  16. Kauppinen M, Saikku P. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis and treatment. Clin Infect Dis 1995; 21: S244-52.

  17. Moazed T, Kuo C, Grayston T et al. Evidence of Systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998; 177: 1322-5.

  18. Shemer-Avni Y, Lieberman D. Chlamydia pneumoniae induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis 1995; 171: 1274-8.

  19. Anttila T, Leinonen M, Marja SH. IgG subclass specific antibodies in Chlamydia pneumoniae infections. Scand J lnfect Dis 1998; 30: 381-6.

  20. Numazaki K, Chiba S. Serum gamma interferon in patients with pneumonia caused by Chlamydia pneumoniae. Pediatr J Infect Dis 1998; 15: 174-5.

  21. Kalayoglu MV, Hoerneman B, La Verda D. Cellular oxidation of Low Density Lipoprotein by Chlamydia pneumoniae. J Infect Dis 1999; 180:780-90.

  22. Bachmaier K, Neu N, de la Maza LM. Chlamydia infections and heart disease linked trough antigenic mimicry. Science 1999; 283: 1335-9.

  23. Hahn D, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol 1998; 81: 339-41.

  24. Hahn D, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult onsetasthma. JAMA 1991; 266: 225-230.

  25. Bone R. Chlamydia pneumonia and asthma: A potentially important relationship. JAMA 1991; 266: 265.

  26. Emre U, Roblin P, Gelling M. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148: 727-32.

  27. Korppi M, Leionen M. Chlamydial infection and reactive airway disease. Arch Pediatr Adolesc Med 1995; 149: 341-2.

  28. Bjömsson E, Hjelm E, Janson C. Serology of Chlamydia in relation to asthma and bronchial hyperresponsiveness. Scand Infect Dis 1996; 28: 63-9.

  29. Johnston SL. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma. Pediatr Pulmonol 1997 suppl; 16: 88-9.

  30. Emre U, Sokolovskaya N, Roblin P. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995; 172: 265-7.

  31. Cook PJ, Tunnicliffe W, Ayres JG et al. Chlamydia pneumoniae and asthma. Thorax 1998; 53: 254-9.

  32. Normann E, Nääs J, Gnarpe J. Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki disease. Pediatr Infecti Dis 1999; 18: 72-3.

  33. Stratton S, Yao S, Tharp A. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46: 6-14.

  34. Hahn D, Bukstein D, Luskin A. Evidence for Chlamydia pneumoniae infection in steroid dependent asthma. Annn Allergy Asthma Immunol 1998; 80: 45-9.




2020     |     www.medigraphic.com